ENVALITH
アース製薬株式会社 logo

Earth Corporation

4985・Prime Market・Chemicals

アース製薬株式会社 logo
Earth Corporation4985

Household Products Business

Earth Corporation's core segment. Develops insect control, daily necessities, gardening, and pet products both domestically and internationally.

PeriodCurrentPreviousChange
Sales (including intersegment) [Cumulative Q1 2026]¥42,962 million¥40,665 million (Cumulative Q1 2025)↑
Segment profit (operating income) [Cumulative Q1 2026]¥6,276 million¥6,081 million (Cumulative Q1 2025)↑
Sales (including intersegment) [Full year, prior year results]¥156,652 million (Full year, FY2025 ending December 2025)–—
Segment profit (operating income) [Full year, prior year results]¥6,501 million (Full year, FY2025 ending December 2025)–—
Insect control products segment sales [Cumulative Q1 2026]¥22,388 million¥20,510 million (Cumulative Q1 2025)↑
Daily necessities segment sales [Cumulative Q1 2026]¥15,220 million¥15,817 million (Cumulative Q1 2025)↓
Gardening products segment sales [Cumulative Q1 2026]¥2,466 million¥1,256 million (Cumulative Q1 2025)↑
Pet Products & Others segment sales [Cumulative Q1 2026]¥2,886 million¥3,081 million (Cumulative Q1 2025)↓

Business Details

Manufactures and sells household insect control products (Gokiburi Hoihoi, Earth No Mat, etc.), oral care products (Mondamin), bath additives (Kikiyu, BARTH, etc.), deodorizers/air fresheners, dehumidifiers and other daily necessities, gardening products, and pet products. In addition to domestic sales, the company positions overseas expansion through local subsidiaries in Thailand, Malaysia, Vietnam, China, the Philippines and other ASEAN/China markets, along with exports to approximately 50 countries worldwide, as a growth driver. Main customers include PALTAC Corporation, ARATA Corporation, and OHKI Co., Ltd. Effective January 1, 2026, the company absorbed its wholly owned subsidiary Bathclin Corporation through merger, promoting optimal allocation of group management resources.

Recent Overview

Insect control and gardening products drove a 5.6% increase in sales; bath additives and oral care struggled. Bathclin merger completed.

In Q1 2026 (January-March), the Household Products Business was driven by insect control products (+9.2%) amid higher temperatures and gardening products (+96.4%) due to the contribution from Protoleaf Co., Ltd., achieving sales of ¥42,962 million (up 5.6% year on year) and segment profit of ¥6,276 million (up 3.2% year on year). Meanwhile, bath additives (down 10.0% due to weak Bathroman and Bathclin powder-type products), oral care products (down 4.1%), and pet products (down 6.3%) fell below the prior year. Effective January 1, 2026, the company absorbed its wholly owned subsidiary Bathclin through merger, removing it from the scope of consolidation. As a subsequent event, a resolution was made to dissolve and close the Chinese subsidiary Ansu Household Chemicals (Suzhou) Co., Ltd.

Key Products

product
Insect Control Products

Deploys Gokiburi Hoihoi, Earth No Mat, insect repellents, and other products. In Q1 2026, temperatures ran higher than the prior year, leading to a favorable market start, with nuisance insect products and insect repellents continuing to perform well. New products this spring, including "Earth OH! No Mat," also drove growth in fly/mosquito products. Overseas, sales exceeded the prior year in Thailand and China, among others. Sales were ¥22,388 million (up 9.2% year on year).

product
Daily Necessities (Oral Care, Bath Additives, Others)

For oral care products (Mondamin, etc.), although the market size exceeded the prior year, shipments fell below the prior year, resulting in sales of ¥1,809 million (down 4.1% year on year). For bath additives, while Onpo and BARTH performed well, powder-type products such as Bathroman and Bathclin declined significantly, resulting in sales of ¥5,512 million (down 10.0% year on year). Other daily necessities, including deodorizers/air fresheners, exceeded the prior year, with sales of ¥7,898 million (up 1.2% year on year). Total sales for the daily necessities segment were ¥15,220 million (down 3.8% year on year).

product
Gardening Products

In addition to the sales contribution from Protoleaf Co., Ltd., newly consolidated from the previous fiscal year, the category performed well, driven mainly by gardening insect control products and herbicides. Q1 2026 sales grew substantially to ¥2,466 million (up 96.4% year on year). Note that this category has been presented as a separate segment apart from the "Insect Control Products" segment since the previous fiscal year.

product
Pet Products & Others

The pet-related market remained stable, with a trend of increasing spending per pet. Care products such as cat litter maintained strong performance. Meanwhile, the MA-T business progressed as planned but fell below the prior year in Q1. Sales were ¥2,886 million (down 6.3% year on year).

product
Overseas Business (ASEAN, China, Exports)

Pursues aggressive expansion in ASEAN and China, as well as growth of export operations. In Q1 2026, performance in Thailand and China, among others, exceeded the prior year, with overseas sales in the insect control products segment contributing to overall growth. Regarding the Chinese consolidated subsidiary Ansu Household Chemicals (Suzhou) Co., Ltd., a resolution to dissolve and close the entity was made at the Board of Directors meeting on May 13, 2026 (subsequent event).

Growth Drivers

  • A favorable market start for insect control products amid higher temperatures, and growth in new products (Earth OH! No Mat, etc.)
  • Rapid expansion of the gardening products segment (up 96.4% year on year) due to the newly consolidated Protoleaf Co., Ltd.
  • Expanding market share and overseas sales growth in ASEAN markets such as Thailand and China
  • Optimal allocation of group management resources and improved business efficiency through the Bathclin merger
  • Continued steady shipments of other daily necessities such as deodorizers/air fresheners
  • Sustained strong performance of pet care products such as cat litter, and stable growth in the pet-related market

Risks

  • Continued significant decline in powder-type bath additive products such as Bathroman and Bathclin
  • Weakening sales strength in oral care products, with shipments falling below the prior year despite market size expansion
  • Stagnant domestic consumer spending due to sluggish real wage growth amid rising prices
  • Upward pressure on selling, general and administrative expenses due to increased personnel costs, advertising expenses, and transportation costs
  • Continued foreign exchange risk and rising raw material prices
  • Risk of returns and disposal losses for insect control products (demand fluctuations due to climate change)
  • Impact of the contraction of China operations due to the dissolution of the Chinese consolidated subsidiary Ansu Household Chemicals (Suzhou) Co., Ltd.
  • Delays in nurturing new businesses due to the continued year-on-year decline in the MA-T business

Integrated Environmental Sanitation Business

A specialized sanitation management service business targeting mainly food and pharmaceutical factories and similar customers

PeriodCurrentPreviousChange
Sales (Cumulative Q1, FY2026 ending December 2026)¥8,415 million¥7,729 million↑
Segment profit (operating income) (Cumulative Q1, FY2026 ending December 2026)¥281 million¥212 million↑
Operating margin (Cumulative Q1, FY2026 ending December 2026)3.3%2.7%↑
Sales (Full year, FY2025 ending December 2025)¥34,148 million——
Segment profit (operating income) (Full year, FY2025 ending December 2025)¥1,530 million——

Business Details

Provides a wide range of sanitation management services covering the entire supply chain of food, pharmaceuticals, logistics, medical institutions, and other sectors, including foreign matter contamination prevention, sterilization work, pest control, GMP/HACCP consulting, FSSC/ISO implementation support, microbial testing, and factory design. The business has a stable revenue model centered on annual contracts, and is also advancing the development of next-generation services utilizing IoT and AI, with the Saito Research Institute serving as its core hub.

Recent Overview

Sales up 8.9% on increased annual contract count, with operating income up sharply by 32.6%

For the cumulative first quarter of FY2026 (ending December 2026), sales reached ¥8,415 million (up 8.9% year on year) and segment profit reached ¥281 million (up 32.6% year on year). Despite a rise in cost ratio and increased personnel costs from active investment in human resources, the number and value of annual contracts continued to grow amid rising sanitation management needs centered on food and pharmaceutical factories, with the increase in revenue outweighing the increase in costs.

Key Products

service
Integrated Environmental Sanitation Management Service

An on-site sanitation management service centered on pest control, sterilization work, and foreign matter contamination prevention. The core service that secures stable revenue through the accumulation of annual contracts.

service
GMP/HACCP & Food Safety Consulting

Provides expert support to strengthen customers' quality control systems, including support for obtaining certifications such as FSSC22000 and ISO22000, food safety auditing services, and GMP compliance support.

service
Environmental Cleanliness Survey & Microbial Testing

A service that scientifically evaluates and analyzes microbial contamination conditions within factories, leveraging the research and technology development capabilities of the Saito Research Institute. Demand from the life sciences industry is also expanding.

platform
IoT-Based Next-Generation Sanitation Management Service

A next-generation service that utilizes digital technologies such as IoT and AI to achieve real-time monitoring and preventive sanitation management. Strengthens the response to customer needs for labor savings and productivity improvement.

Growth Drivers

  • Continued rising needs for foreign matter contamination countermeasures and sanitation management at food and pharmaceutical factories
  • Steady accumulation of sales through consistent growth in the number and value of annual contracts
  • Expansion of sanitation management support and food safety auditing services for the pharmaceutical and regenerative medicine (life sciences) industries
  • Advancement of next-generation service development and value enhancement through the use of IoT and AI
  • Strengthening of human resource development and research/technology development centered on the Saito Research Institute
  • Expanding opportunities to acquire new customers amid a recovery in capital investment in the manufacturing industry

Risks

  • Rising cost ratio and profit pressure due to soaring personnel costs and material/equipment prices
  • Constraints on service delivery capacity due to labor shortages and difficulty securing human resources
  • Stricter cost-effectiveness evaluation of sanitation management investment by customers
  • Risk of delayed response to customer needs for labor savings and productivity improvement
  • Impact on contract retention and expansion if differentiation from competitors is insufficient

Last updated: July 17, 2026